HIV care consortia and coverage of medications

AIDS and Public Policy Journal

Volumn 17, Issue 2, 2002, Pages 37-58

  Buchanan, Robert J ^b   Smith, Scott R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DRUG COST; FINANCIAL MANAGEMENT; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAID; MEDICAL SERVICE; MEDICARE; NON PROFIT ORGANIZATION; PATIENT CARE; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; REVIEW; UNITED STATES;

EID: 0010199606     PISSN: 08873852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Health Resources and Services Administration, 2000, "Care Act: Programs and Funding," available at 〈http://hab.hrsa.gov/careindex.html〉.
2. Health Resources and Services Administration, 2000, Ryan White CARE Act, available at 〈http://hab.hrsa.gov/A/4web/act.htm〉.
3. See note 1 above.
4. I b i d.
5. I b i d.
6. I b i d.
7. Health Resources and Services Administration, 2000, "The Ryan White CARE Act: AIDS Drug Assistance Programs (ADAPs)," available at 〈http://www.hrsa.gov/hab〉.
8. I b i d.
9. S. Smith and R. Buchanan, "The AIDS Drug Assistance Programs and Coverage of HIV-Related Medications" Annals of Pharmacotherapy 35 (2001): in press.
10. I b i d.
11. F.J. Palella et al., "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection," New England Journal of Medicine 338 (1998): 853-60; R. Moore and R. Chaisson, "Natural History of HIV Infection in the Era of Combination Antiretroviral Therapy," AIDS 13 (1999): 1932-42; P. Weidle, S. Holmberg, and K. DeCock, "Changes in HIV and AIDS Epidemiology from New Generation Therapy," AIDS 13 (1999): S61-8.
12. F.J. Palella et al., "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection," New England Journal of Medicine 338 (1998): 853-60; R. Moore and R. Chaisson, "Natural History of HIV Infection in the Era of Combination Antiretroviral Therapy," AIDS 13 (1999): 1932-42; P. Weidle, S. Holmberg, and K. DeCock, "Changes in HIV and AIDS Epidemiology from New Generation Therapy," AIDS 13 (1999): S61-8.
13. F.J. Palella et al., "Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection," New England Journal of Medicine 338 (1998): 853-60; R. Moore and R. Chaisson, "Natural History of HIV Infection in the Era of Combination Antiretroviral Therapy," AIDS 13 (1999): 1932-42; P. Weidle, S. Holmberg, and K. DeCock, "Changes in HIV and AIDS Epidemiology from New Generation Therapy," AIDS 13 (1999): S61-8.
14. R. Moore and R. Chaisson, "Natural History of Opportunistic Disease in an HIV-Infected Urban Clinical Cohort," Annals of Internal Medicine 124 (1996): 633-42.
15. R. Buchanan, B. Chakravorty, and S. Smith, "Eligibility Policies for the State AIDS Drug Assistance Programs," Social Work in Health Care 32, no. 3 (2001): 81-104.
16. R. Buchanan, A 2000 Survey of Eligible Metropolitan Areas Funded by Title I of the Ryan White CARE Act.
17. Office of Management and Budget, "Fiscal Year 2002 Budget," available at lang;http://www.access.gpo.gov/usbudget〉; Community Health Funding Report (Silver Spring, Md.: CD Publications, 12 April 2001).
18. Office of Management and Budget, "Fiscal Year 2002 Budget," available at lang;http://www.access.gpo.gov/usbudget〉; Community Health Funding Report (Silver Spring, Md.: CD Publications, 12 April 2001).